VOLUME 9 (2018)
Table of Contents
News
|
| DVL regulation of tissuespecific aromatase transcripts in breast cancer |
|
https://doi.org/10.18632/oncotarget.26496
|
| 37458-37459 |
Editorial
|
| MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome |
|
https://doi.org/10.18632/oncotarget.26477
|
| 37460-37461 |
|
| Examining rare side effects in pooled trial data: symptomatic osteonecrosis in Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.26486
|
| 37462-37463 |
|
| Targeting melanoma residual disease by USP7 |
|
https://doi.org/10.18632/oncotarget.26497
|
| 37464-37465 |
|
| Targeting anticancer druginduced senescence in glioblastoma therapy |
|
https://doi.org/10.18632/oncotarget.26502
|
| 37466-37467 |
|
| Novel insights into endothelial cell malignancies |
|
https://doi.org/10.18632/oncotarget.26516
|
| 37468-37470 |
Research Papers
|
| Linc00441 interacts with DNMT1 to regulate RB1 gene methylation and expression in gastric cancer |
|
https://doi.org/10.18632/oncotarget.23928
|
| 37471-37479 |
|
| NKL homeobox gene NKX22 is aberrantly expressed in Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.26459
|
| 37480-37496 |
|
| Epithelial insulin receptor expression – prognostic relevance in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26490
|
| 37497-37508 |
|
| Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma |
|
https://doi.org/10.18632/oncotarget.26493
|
| 37509-37519 |
|
| Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26494
|
| 37520-37533 |
|
| Accurate diagnosis of mismatch repair deficiency in colorectal cancer using highquality DNA samples from cultured stem cells |
|
https://doi.org/10.18632/oncotarget.26495
|
| 37534-37548 |
|
| PARP inhibition prevents escape from a telomeredriven crisis and inhibits cell immortalisation |
|
https://doi.org/10.18632/oncotarget.26499
|
| 37549-37563 |
|
| TLR4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas |
|
https://doi.org/10.18632/oncotarget.26500
|
| 37564-37580 |
|
| Interest to consider rechallenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer |
|
https://doi.org/10.18632/oncotarget.26506
|
| 37581-37588 |
Reviews
|
| Targeted therapies for advanced nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26428
|
| 37589-37607 |
Corrections
|
| Correction: Hypoxia/reoxygenationexperienced cancer cell migration and metastasis are regulated by Rap1 and Rac1GTPase activation via the expression of thymosin beta4 |
|
https://doi.org/10.18632/oncotarget.26543
|
| 37608-37609 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
